NeuroEM Therapeutics, Inc. — Form D
NeuroEM Therapeutics, Inc. of TAMPA, FL, a company, filed a Form D exempt-offering notice with the SEC on 2025-04-23. The offering totals $6.5M, of which $1.9M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2025-04-23
- Form: D
- Accession: 0002026871-25-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $6.5M
- Amount sold: $1.9M
- Remaining: $4.5M
- Investors: 23
- Date of first sale: 2025-04-09
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-544263
Issuer
- Name: NeuroEM Therapeutics, Inc.
- CIK: 0002026871
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 501 E KENNEDY BOULEVARD, TAMPA, FL, 33602
- Phone: 727-252-6120
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Jonathan Gordon | Director | Pompano Beach, FL |
| Mitch Larimore | Director | Tampa, FL |
| Chuck Papageorgiou | Director | Tampa, FL |
| Chuck Papageorgiou | Executive Officer | Tampa, FL |
Other filings by this issuer (1)
More